English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Aim: To assess feasibility, safety and long-term outcome of a water-soluble contrast agent (GastrografinTM) in surgical neonates/infants who present with ABSO. Method: 18 Neonates, who continued to exhibits signs of intestinal obstruction after one week post surgery, were given 1-2 mls/kg of oral Gastrografin for 5-8 days. Result: All but one patient could be fed within 12 hours and discharged home soon afterwards. A single patient retuned 6 months later with ABSO and was similarly treated again. There was no mobility or mortality due to this technique. Main Conclusion: Gastrografin contrast give orally can result in relief of ABSO, as similarly described in adult and older children.

Oral Water-Soluble Contrast Agent as the Definitive Treatment of Uncomplicated Adhesive Bowel Obstruction in Infants and Neonates